X

Eddy Sunarto

Eddy spent the best part of the last decade in Tokyo and London, gaining experience at investment banks and learning hands on about the financial markets. He's always been an enthusiastic follower of Australian equities, even when living overseas. Now back in Australia, he joins Stockhead keen on applying his market knowledge to cover breaking news on multiple ASX sectors.

Closing Bell: ASX clipped -1.3pc on broad selloff; BHP makes a $60bn play for Anglo American

The ASX slumped by over -1pc, as jitters about delayed rate cuts rattled markets Miner BHP confirmed  $60 billion bid…

ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential

Recce Pharma cleared to increase R327's minimum dose. R327 can now be administered at 4,000mg over a fast infusion of…

Market Highlights: Google, Microsoft boost Wall Street post-hours; and what’s the risk for gold from here?

ASX to slump on Friday after Wall Street declined. The US market got a boost post-hours after Alphabet and Microsoft…

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners

There's been a breakthrough in acne treatment. Scientists have found a way to use skin bacteria to control sebum production.

Closing Bell: ASX’s gains erased after strong CPI, winning tickers today include WMS and OZM

The ASX pared gains after the CPI came in stronger than expected Fortescue led the Mining sector after its quarterly…

Market Highlights: Tesla surges after Q1 update, iron ore slumps, and 5 ASX small caps to watch today

ASX to extend gains on Wednesday after Wall Street bounced back. Tesla surged by 11pc after releasing quarterly results.

MoneyTalks: Here’s one ASX defence stock that could emerge a winner from geopolitical tailwinds

Sequoia initiates coverage on Highcom amid geopolitical tailwinds. Highcom has evolved into a leading provider of body armour protection.

Closing Bell: Tech stocks in demand ahead of Tesla results; Osteopore up 130pc on clinical trial news

The ASX extends its gains on Tuesday Tech stocks rallied ahead of US megacap earnings, while goldies struggled Tesla, along…

Market Highlights: US megacaps up on dip buying ahead of earnings; and 5 ASX small caps to watch

ASX to climb again on Tuesday as focus turns to the Magnificent 7. US megacaps stocks will be reporting their…

Things you may not know about Made in Australia, and ASX stocks that manufacture right here

The Albanese government announced the Future Made in Australia Act. Stockhead reached out to Australian Made CEO, Ben Lazzaro.

Closing Bell: A big relief rally for the ASX today; copper continues its bull market rally

The ASX staged a relief rally on Monday Gold, oil stocks struggled after tensions in the Middle East eased The…

Market Highlights: US$200bn wiped out from Nvidia, and 5 ASX small caps to watch on Monday

ASX to gain some backas Middle East tensions seem to have eased a little following Friday’s strikes by Israel. S&P…

Hot Money Monday: The Turtle Trading System is the most celebrated momentum strategy; here’s how it works

The most celebrated momentum-following strategy is the The Turtle Trading System, which was created during the 1980s.

The Ethical Investor: Why the space industry could be the next frontier for ESG investors

Why space is the final frontier in ESG investing Space technology solves humanity's most daunting challenges including climate change How…

Closing Bell: Israel’s strikes grip markets; oil and gold spike while the ASX tumbles over 1pc

The ASX closed more than 1pc lower after strong US jobs report and Israeli attack on Iran The Israeli retaliation…

ASX Health Stocks: Paradigm responds to US FDA, seeks marketing approval from TGA

Paradigm Biopharma submits response to the FDA. INOVIQ says its blood test on ovarian cancer is highly accurate.

Market Highlights: Netflix shares dumped, Bitcoin halving looms, and 5 ASX small caps to watch today

ASX to fall on the back of strong US jobs report. Netflix down 5pc after Q1 results, and Bitcoin halving…

Don't be the last to know

  • By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.